Clinical significance of atrial high-rate episodes for thromboembolic events in Japanese population
نویسندگان
چکیده
Objective The clinical significance of atrial high-rate episodes (AHREs) detected by cardiac devices among patients with implantable pacemakers has recently emerged. However, the relationship between AHREs and ischaemic stroke and systemic embolism (SE) is not well understood in the Japanese population. Methods This study included 343 patients with pacemakers capable of continuous atrial rhythm monitoring (167 males; mean age, 80±7 years). Atrial tachyarrhythmia detection was programmed to the nominal setting of each device, and AHRE was defined as any episode of sustained atrial tachyarrhythmia lasting for more than 6 min. Thromboembolic risk was defined based on the CHADS2 score. Results During the follow-up period (52±30 months), 165 (48%) patients had at least one episode of AHREs, and 19 (6%) patients experienced stroke/SE. Among patients who experienced stroke/SE, 14 had AHREs before the stroke/SE. AHREs were significantly associated with stroke/SE (HR 2.87; 95% CI 1.10 to 8.90; p=0.03). Subgroup analysis conducted to investigate the impact of the CHADS2 score severity on stroke/SE revealed that AHREs were not associated with stroke/SE in patients with low or intermediate thromboembolic risk (CHADS2 score 0-2; n=217). In contrast, among patients with high thromboembolic risk (CHADS2 score>2; n=126), there was a significant association between AHREs and the incidence of stroke/SE (HR 3.73; 95% CI 1.06 to 13.1; p=0.04). Conclusion AHREs detected by pacemaker were associated with ischaemic stroke/SE in the Japanese population. However, this association was observed only in the high thromboembolic risk group.
منابع مشابه
Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure–cardiac resynchronization therapy population
AIMS Uncertainty exists over the importance of device-detected short-duration atrial arrhythmias. Continuous atrial diagnostics, through home monitoring (HM) technology (BIOTRONIK, Berlin, Germany), provides a unique opportunity to assess frequency and quantity of atrial fibrillation (AF) episodes defined as atrial high-rate events (AHRE). METHODS AND RESULTS Prospective data from 560 heart f...
متن کاملIndependent Effect of Digoxin in Preventing Atrial Fibrillation in High Risk Patients after CABG Surgery
Background: Atrial fibrillation (AF) is one of the most common arrhythmias after coronary artery bypass graft (CABG) surgery. AF can result in hemodynamic instability, thromboembolic events, increase the perioperative myocardial infarction, congestive heart failure, stroke, more length of hospital stay (LOHS) and cost of treatment. The aim of this study was to evaluate the independent effect of...
متن کاملThromboembolic episodes related to atrial arrhythmias in adults with transposition of great arteries
Background: Atrial arrhythmias (AA) are common in adults with congenital heart disease (ACHD). Although Intra-atrial Reentrant Tachycardia (IART) is well described in ACHD, Atrial Fibrillation (AF) is uncommon, but increasingly recognized. Patients with Transposition of the Great Arteries (TGA) and congenitally corrected-TGA (CC-TGA) have a high burden of AA at a relatively young age. However, ...
متن کاملIs low body weight a novel risk factor for thromboembolic events in patients with non-valvular atrial fibrillation?
In this issue of the Journal, Hamatani et al5 address this important issue by analyzing data from the Fushimi AF Registry, a community-based Japanese prospective cohort. Patients with low body weight (LBW: ≤50 kg) showed a higher risk profile and a higher incidence of stroke/SE, but no difference in the incidence of major bleeding compared with those over 50 kg using multivariate and propensity...
متن کاملInflammation and atrial fibrillation.
trial fibrillation (AF) is a highly prevalent arrhythmia associated with significant morbidity and mortality because of the hemodynamic impairment and thromboembolic events. AF affects 1–1.5% of the population worldwide; it has been estimated that 2.2 million people in the USA and 4.5 million in Europe have paroxysmal or persistent AF. The estimated prevalence of AF was 0.6% in the Japanese gen...
متن کامل